Reilly J. Chronic neutrophilic leukaemia: a distinct clinical entity?. Br J Haematol. 2002;116:10-8 pubmed
Reilly J. FLT3 and its role in the pathogenesis of acute myeloid leukaemia. Leuk Lymphoma. 2003;44:1-7 pubmed
..FLT3, therefore, is a potentially important molecular target for AML therapy and already phase I clinical trials have been initiated. ..
Reilly J. Pathogenetic insight and prognostic information from standard and molecular cytogenetic studies in the BCR-ABL-negative myeloproliferative neoplasms (MPNs). Leukemia. 2008;22:1818-27 pubmed publisher
..A brief overview is given of the cytogenetic findings in the individual diseases, followed by a more detailed discussion of the possible pathogenetic consequences of specific abnormalities and their impact on prognosis. ..
Reilly J, McMullin M, Beer P, Butt N, Conneally E, Duncombe A, et al. Guideline for the diagnosis and management of myelofibrosis. Br J Haematol. 2012;158:453-71 pubmed publisher
Reilly J. Class III receptor tyrosine kinases: role in leukaemogenesis. Br J Haematol. 2002;116:744-57 pubmed